Ontology highlight
ABSTRACT:
SUBMITTER: Stolzel F
PROVIDER: S-EPMC9977313 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
Stölzel Friedrich F Fordham Sarah E SE Nandana Devi D Lin Wei-Yu WY Blair Helen H Elstob Claire C Bell Hayden L HL Mohr Brigitte B Ruhnke Leo L Kunadt Desiree D Dill Claudia C Allsop Daniel D Piddock Rachel R Soura Emmanouela-Niki EN Park Catherine C Fadly Mohd M Rahman Thahira T Alharbi Abrar A Wobus Manja M Altmann Heidi H Röllig Christoph C Wagenführ Lisa L Jones Gail L GL Menne Tobias T Jackson Graham H GH Marr Helen J HJ Fitzgibbon Jude J Onel Kenan K Meggendorfer Manja M Robinson Amber A Bziuk Zuzanna Z Bowes Emily E Heidenreich Olaf O Haferlach Torsten T Villar Sara S Ariceta Beñat B Diaz Rosa Ayala RA Altschuler Steven J SJ Wu Lani F LF Prosper Felipe F Montesinos Pau P Martinez-Lopez Joaquin J Bornhäuser Martin M Allan James M JM
JCI insight 20230124 2
Precision medicine can significantly improve outcomes for patients with cancer, but implementation requires comprehensive characterization of tumor cells to identify therapeutically exploitable vulnerabilities. Here, we describe somatic biallelic TET2 mutations in an elderly patient with acute myeloid leukemia (AML) that was chemoresistant to anthracycline and cytarabine but acutely sensitive to 5'-azacitidine (5'-Aza) hypomethylating monotherapy, resulting in long-term morphological remission. ...[more]